Skip to main content
Elliott Vichinsky, MD, Pediatric Hematology & Oncology, Oakland, CA

Elliott P Vichinsky MD


Medical Director, Hematology/Oncology Dept, Children's Hospital & Research Center Oakland

Join to view full profile
  • 747 52nd StOakland, CA 94609

  • Phone+1 510-428-3651

  • Fax+1 510-450-5647

Dr. Vichinsky is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • U Washington Affil Hosps
    U Washington Affil Hosps1976 - 1979
  • University of Washington
    University of WashingtonResidency, Pediatrics, 1974 - 1976
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1974, MD, CUM LAUDE ALPHA OMEGA ALPHA

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - 2028
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Super Doctor SuperDoctors.com
  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Transfusion Practices and Complications in Thalassemia  
    Vinod V Balasa, Sanjay J Shah, Monica B Pagano, Geetha Puthenveetil, Jennifer Andrews, Ashutosh Lal, Trisha E Wong, Alan K Ikeda, Jong H Chung, Jennifer C Yu, Elliott ..., Transfusion
  • A Phase 3 Trial of L-glutamine in Sickle Cell Disease  
    Rita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine

Abstracts/Posters

  • Trends in Iron Overload over Past Two Decades: Results from the Natural History of Iron Burden Study with the SQUID BiosusceptometerClinically Relevant Abstract
    Elliott Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/2019
  • Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress
    Elliott P. Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Correlation of Voxelotor Exposure with Hemoglobin Response and Measures of Hemolysis in Patients from the HOPE Study
    Elliott Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Moving From Science Fiction to Clinical Reality: Gene Therapy for Beta-Hemoglobinopathies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • Sickle Cell Math Is Brutally Simple, but Not Widely Taught
    Sickle Cell Math Is Brutally Simple, but Not Widely TaughtDecember 28th, 2021
  • CRISPR Gene-Editing Clinical Trial at UCSF Aims to Cure Deadly Blood Disease
    CRISPR Gene-Editing Clinical Trial at UCSF Aims to Cure Deadly Blood DiseaseDecember 28th, 2021
  • Sickle Cell Gift Adds $2M to Oakland Hospital’s Growing Program
    Sickle Cell Gift Adds $2M to Oakland Hospital’s Growing ProgramDecember 16th, 2021

Grant Support

  • Zinc Supplementation in SCD: A Precursor to the Think Zinc for Bones TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2025–2027
  • Prevention Of Complications In ThalassemiaCenters For Disease Control And Prevention2007–2011
  • Modulation Of Iron Deposition In SCD And Other HemoglobinopathiesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • Ninth Cooley'S Anemia SymposiumNational Heart, Lung, And Blood Institute2009
  • Thalassemia Clinical Research NetworkNational Heart, Lung, And Blood Institute2005–2009

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: